Curalin|Klínískt rannsakaður blóðsykursstuðningur|180 hylki
Curalin|Klínískt rannsakaður blóðsykursstuðningur|180 hylki
ÍTARLEGRI UPPLÝSINGAR
Innihaldsefnin:
Curcumin (Curcuma Longa):
1. Curcuma longa and Curcumin: A review article
2. Curcumin and Diabetes: A systematic Review
3. Curcumin extract for prevention of type 2 diabetes
Zeilon kanill (Cinnamomum Verum):
1. The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials
Amla (Phyllanthus Emblica):
2. Phyllanthus emblica Linn. (Amla) - A Natural Gift to Humans: An Overview
Fenugreek (Trigonalle Foenum-Graecum)
- Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study
- Fenugreek galactomannan and citrus pectin improve several parameters associated with glucose metabolism and modulate gut microbiota in mice
Syzygium Cumini:
Bitter Melon (Momordica Charantia):
- Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients
- Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients
- Momordica charantia and type 2 diabetes: from in vitro to human studies
- Beneficial effect and mechanism of action of Momordica charantia in the treatment of diabetes mellitus: A mini review
Swertia Chirata:
- A Review of Swertia chirayita (Gentianaceae) as a Traditional Medicinal Plant
- Swertia chirayita – an overview
Picrorhiza Kurroa (Neopicrorhiza):
Gymnema Sylvestre
- In Vitro micropropagation of Gymnema sylvestre – A multipurpose medicinal plant
- An overview on the advances of Gymnema sylvestre: chemistry, pharmacology and patents
- A systematic review of Gymnema sylvestre in obesity and diabetes management
- Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients
Upplýsingum sem eru á síðunni er ekki ætlað að koma í stað tilmæla eða ráðgjafar fagfólks í heilbrigðisþjónustu.
Sjúklingar á lyfjum, sérstaklega þeir sem haldnir eru alvarlegum sjúkdómum ættu að ráðfæra sig við lækni áður en þeir hefja neyslu bætiefna.
Ekki skal neyta meira af vörunni en ráðlagður neysluskammtur segir til um.
Fæðubótarefna skal ekki neyta í stað fjölbreyttrar fæðu.
Geyma skal vöruna þar sem börn ná og sjá ekki til.
© 2026 Heilsubarinn ehf. Allur réttur áskilinn.